CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer

被引:0
|
作者
M Fukuoka
N Masuda
S Negoro
K Matsui
T Yana
S Kudoh
Y Kusunoki
M Takada
M Kawahara
M Ogawara
N Kodama
K Kubota
K Furuse
机构
[1] Osaka Prefectural Habikino Hospital,Department of Internal Medicine
来源
British Journal of Cancer | 1997年 / 75卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Sixty-three patients with extensive-stage small-cell lung cancer were randomized to receive either cyclophosphamide, vincristine, doxorubicin and etoposide (CODE) alone or CODE plus recombinant human granulocyte colony-stimulating factor (rhG-CSF). rhG-CSF administration in support of CODE chemotherapy resulted in increased mean total received dose intensity for all drugs (P = 0.03) with a significant improvement in survival (P = 0.004).
引用
收藏
页码:306 / 309
页数:3
相关论文
共 50 条
  • [1] CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
    Fukuoka, M
    Masuda, N
    Negoro, S
    Matsui, K
    Yana, T
    Kudoh, S
    Kusunoki, Y
    Takada, M
    Kawahara, M
    Ogawara, N
    Kodama, N
    Kubota, K
    Furuse, K
    [J]. BRITISH JOURNAL OF CANCER, 1997, 75 (02) : 306 - 309
  • [2] CODE CHEMOTHERAPY WITH OR WITHOUT RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER
    MASUDA, N
    FUKUOKA, M
    FURUSE, K
    NAGATA
    BUNN, PA
    GRECO, FA
    [J]. ONCOLOGY, 1992, 49 : 19 - 24
  • [3] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF SMALL-CELL LUNG-CANCER
    WOLF, M
    KLAUSMANN, M
    HAVEMANN, K
    [J]. SEMINARS IN ONCOLOGY, 1994, 21 (06) : 51 - 56
  • [4] REDUCTION BY GRANULOCYTE COLONY-STIMULATING FACTOR OF FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER
    CRAWFORD, J
    OZER, H
    STOLLER, R
    JOHNSON, D
    LYMAN, G
    TABBARA, I
    KRIS, M
    GROUS, J
    PICOZZI, V
    RAUSCH, G
    SMITH, R
    GRADISHAR, W
    YAHANDA, A
    VINCENT, M
    STEWART, M
    GLASPY, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03): : 164 - 170
  • [5] Weekly CODE chemotherapy with recombinant human granulocyte colony-stimulating factor for relapsed or refractory small cell lung cancer
    Sato, K
    Tsuchiya, S
    Minato, K
    Sunaga, N
    Ishihara, SI
    Makimoto, T
    Naruse, I
    Hoshino, H
    Watanabe, S
    Saitoh, R
    Mori, M
    [J]. ONCOLOGY REPORTS, 2000, 7 (05) : 1135 - 1139
  • [6] Antibiotics plus granulocyte colony-stimulating factor reduces febrile neutropenia in the first cycle of chemotherapy in people with small-cell lung cancer
    Bohlius, Julia
    Engert, Andreas
    [J]. CANCER TREATMENT REVIEWS, 2006, 32 (03) : 234 - 238
  • [7] Dose intensification of chemotherapy and the role of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in small cell lung cancer
    TjanHeijnen, VCG
    Postmus, PE
    Wagener, DJT
    [J]. ANTI-CANCER DRUGS, 1997, 8 (06) : 549 - 564
  • [8] THE ROLE OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN CHEMOTHERAPY FOR LUNG-CANCER
    SAIJO, N
    EGUCHI, K
    ETOU, H
    MIYACHI, S
    MORINARI, H
    NAKADA, K
    NODA, K
    OHKUNI, Y
    WATANABE, K
    YAMADA, Y
    KABE, J
    KUDO, S
    MANO, K
    MORINARI, H
    TANAKA, T
    UZAWA, T
    OHE, Y
    TAMURA, T
    SASAKI, Y
    SHINKAI, T
    [J]. SEMINARS IN ONCOLOGY, 1994, 21 (01) : 54 - 58
  • [9] INFECTION RISK IN PATIENTS WITH SMALL-CELL LUNG-CANCER RECEIVING INTENSIVE CHEMOTHERAPY AND RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR
    GURNEY, H
    ANDERSON, H
    RADFORD, J
    POTTER, MR
    SWINDELL, R
    STEWARD, W
    KAMTHAN, A
    CHANG, J
    WEINER, J
    THATCHER, N
    CROWTHER, D
    [J]. EUROPEAN JOURNAL OF CANCER, 1992, 28A (01) : 105 - 112
  • [10] Cost-effectiveness of adding granulocyte colony-stimulating factor to primary prophylaxis with antibiotics in small-cell lung cancer
    Timmer-Bonte, Johanna N. H.
    Adang, Eddy M. M.
    Smit, Hans J. M.
    Biesma, Bonne
    Wilschut, Frank A.
    Bootsma, Gerben P.
    de Boo, Theo M.
    Tjan-Heijnen, Vivianne C. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 2991 - 2997